L-Glucose: Another Path to Cancer Cells

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Cancer cells exhibit metabolic heterogeneity, with potential for utilizing unusual substrates.
• Understanding cancer cell metabolism is crucial for developing new diagnostic and therapeutic strategies.
• L-glucose, an isomer of D-glucose, is generally unmetabolizable by human cells.

Purpose of the Study:

• To investigate the uptake and utilization of L-glucose by cancer cells.
• To explore the potential of L-glucose tracers for identifying and characterizing malignant tumor cells.
• To correlate L-glucose uptake with tumor cell characteristics like nuclear heterogeneity and mitochondrial activity.

Main Methods:

• Synthesis of fluorescence-emitting L-glucose tracers (fLGs) by conjugating fluorophores to L-glucose.
• Utilizing 2-NBDLG, a specific fLG, to track uptake in tumor cell aggregates (spheroids).
• Analyzing changes in mitochondrial activity and nuclear morphology in cells exhibiting fLG uptake.

Main Results:

• The fLG 2-NBDLG was unexpectedly and specifically taken up by tumor cell aggregates (spheroids).
• fLG uptake correlated with nuclear heterogeneity, a key indicator of malignancy.
• Mitochondrial activity changes were observed in tumor cells actively taking up fLG.

Conclusions:

• Fluorescent L-glucose tracers (fLGs) can serve as novel markers for visualizing and characterizing malignant tumor cells.
• Aberrant L-glucose uptake may be linked to tumor heterogeneity and altered mitochondrial function.
• fLGs offer a promising new avenue for cancer cell detection and diagnosis.